Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Canopy ...

Canopy Growth Corp (TSE:WEED – Get Free Report) hit a new 52-week low on Tuesday . The company traded as low as C$2.51 and last traded at C$2.48, with a volume of 736176 shares changing hands. The ...

Even more impressive, though, is how Wall Street thinks Constellation will perform over the next 12 months. The average price ...

Roth/MKM maintained a positive stance on Canopy Growth (NASDAQ:CGC) shares, despite reducing the price target to C$10 from the previous C$15. The firm continues to endorse a Buy rating for the ...

BofA lowered the firm’s price target on Canopy Growth (CGC ... Try Now>> See Insiders’ Hot Stock Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC ...

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.

Not only does Canopy Growth still have a lot of debt remaining, its cash flow from operations continues to be negative. Often, tangible book value can help support a stock price, but this doesn't ...

Canopy Growth Corp.’s stock fell sharply as the Canadian cannabis company’s wider-than-expected third-quarter loss chilled a recent rally in its share price. At the closing bell, Canopy Growth ...